No such message found

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!
Reply New Message
Prev Message Back To Forum Threaded View Next Message

"fair value to shareholders would be an outright sale of the company."

I agree, but how do you get around the ongoing clinical trials with Pfizer and Newsoara plus other partnership interests that presently exist?

https://www.zenithepigenetics.com/programs/business-strategy

Koo

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply